• Harmony Biosciences will present six narcolepsy and idiopathic hypersomnia posters at the SLEEP 2026 annual meeting in Baltimore, June 14-17.
• Presentations run June 15-16, including analyses of pitolisant in narcolepsy and idiopathic hypersomnia.
• Data also cover Phase 3 studies of HBS-301 plus a Phase 1b dosing optimization study of HBS-201.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harmony Biosciences Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260611781016) on June 11, 2026, and is solely responsible for the information contained therein.